Donate now
EN
29 November 2024
Cancer hazard identification Head and neck cancer Non-Hodgkin lymphoma Pharmaceutical drugs Radiation Skin cancer

IARC Monographs evaluation of the carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus


IARC Monographs Meeting 137 Home The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has evaluated the carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus. The outcome of the assessment has been published in a summary article in The Lancet Oncology and will be described in detail in Volume 137 of the IARC Monographs, to be published in 2025. Read the article
Questions and Answers

Questions and Answers

Read the Q&A

Infographic

Infographic

Volume 137 webpage

Volume 137 webpage


Close Reading Mode
UP